Article Information
History
- September 5, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Mark Zobeck, MD, MPH1,2,*,
- Javed Khan, MD3,
- Rajkumar Venkatramani, MD1,2,
- M. Fatih Okcu, MD, MPH1,2,
- Michael E. Scheurer, PhD, MPH1,2 and
- Philip J. Lupo, PhD, MPH1,2
- 1Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, Texas
- 2Texas Children’s Hospital, Texas Children’s Cancer and Hematology Centers, Houston, Texas
- 3Center for Cancer Research, National Cancer Institute, Bethesda, Maryland
- ↵*Correspondence: Mark Zobeck, Department of Pediatrics, Baylor College of Medicine, Department of Pediatrics, One Baylor Plaza, MS BCM 622, Houston, TX 77030., Email: Mark.Zobeck{at}bcm.edu., Twitter/X: @MarkZobeck
Posted September 05, 2024.
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers
